In Goldman Sachs's report, "The Genome Revolution," its analysts ponder the rise of biotech companies who believe they will develop "one-shot" cures for chronic illnesses; in a moment of rare public frankness, the report's authors ask, "Is curing patients a sustainable business model?"
The analysis is to see if it is bad for business in the long run. I
"The potential to deliver 'one shot cures' is one of the most attractive aspects of gene therapy, genetically-engineered cell therapy and gene editing. However, such treatments offer a very different outlook with regard to recurring revenue versus chronic therapies," analyst Salveen Richter wrote in the note to clients Tuesday. "While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow."
Richter cited Gilead Sciences' treatments for hepatitis C, which achieved cure rates of more than 90 percent. The company's U.S. sales for these hepatitis C treatments peaked at $12.5 billion in 2015, but have been falling ever since. Goldman estimates the U.S. sales for these treatments will be less than $4 billion this year, according to a table in the report.
"GILD is a case in point, where the success of its hepatitis C franchise has gradually exhausted the available pool of treatable patients," the analyst wrote. "In the case of infectious diseases such as hepatitis C, curing existing patients also decreases the number of carriers able to transmit the virus to new patients, thus the incident pool also declines … Where an incident pool remains stable (eg, in cancer) the potential for a cure poses less risk to the sustainability of a franchise."
Probably now you can understand why certain diseases are researched more than others, why many diseases never finds a cure, may be the business model explains the intricacies.
Title – A title can be anything from a question, a heading of the article, or even the main topic about which you are publishing the post.
Description – It is explaining and adding the details about the topic you are posting. If you are asking a Question, then adding details is not necessary.
Photo, Video – You can attach a photo related to your post or can even publish a YOUTUBE video.
Sharing – Your name gets automatically attached behind the title of the article when you share is on Facebook or other platforms.
Eg: If a user John Watson have posted an article with the Title “How to handle Migraine without medicines?” and then if anyone share it on Facebook, the title will be like this :
“How to handle Migraine without medicines?”- John Watson
Themes of publishing or asking – You can publish from various themes that we mentioned and if any topic is missing among them, you can still post anything related to the Health. Healthcare is the only broad theme.
This data changes rapidly, so what’s shown may be out of date. Table totals may not always represent an accurate sum. Information about reported cases is also available on the World Health Organisation site.
It doesn’t include all cases
Confirmed cases aren’t all cases. They only include people who tested positive. Testing rules and availability vary by country.